Biosimulation Market 2028 By Product, Application, End User | The Insight Partners

report image

Biosimulation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ( Software, Services ); Application ( Drug Discovery, Drug Development, Others ); End User ( Pharmaceutical and Biotechnology Companies, Academic Research Institutions, Others )

Report Code: TIPHE100001203 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Biosimulation refers to a mathematical simulation of various biological processes, in which computer aided programs are utilized for the simulation of biological systems and processes. Biosimulation is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.


The "Global Biosimulation Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biosimulation market with detailed market segmentation by product, application, end user, and geography. The report provides key statistics on the market status of the leading biosimulation market players and offers key trends and opportunities in the market.


  • Based on product, the global biosimulation market is segmented into software and services.
  • On the basis of application, the market is segmented into drug discovery, drug development and others.
  • Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic research institutions and others.



  • Increasing focus on advanced drug development.
  • Increasing healthcare spending and improved simulation techniques.
  • Rising healthcare expenditure.


  • Lack of standardization


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biosimulation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biosimulation market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the biosimulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biosimulation market are anticipated to lucrative growth opportunities in the future with the rising demand for biosimulation in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biosimulation market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Simulations Plus
  • Certara USA, Inc.
  • Schrödinger, LLC
  • Dassault Systèmes
  • Rosa & Co., LLC
  • Genedata AG
  • Leadscope, Inc.
  • Evidera
  • Advanced Chemistry Development
  • Insilico Biotechnology

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

The List of Companies

1. Simulations Plus
2. Certara USA, Inc.
3. Schrödinger, LLC
4. Dassault Systèmes
5. Rosa & Co., LLC
6. Genedata AG
7. Leadscope, Inc.
8. Evidera
9. Advanced Chemistry Development
10. Insilico Biotechnology
11. Chemical Computing Group
12. Certara
13. Physiomics
14. Nuventra Pharma
15. Inosim Software

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount